In the last few years, many researchers have discovered that mesenchymal stem cells (MSCs) hold the key to treating many serious diseases such as diabetes, Parkinson's disease, and multiple sclerosis. According to the study, ?Prevalence of Parkinson?s disease (PD) across North America?, published in July 2018 in the journal Nature, the number of people suffering from PD is expected to reach 930,000 in 2020 and 1,238,000 in 2030. Thus, high prevalence of such diseases is also expected to aid in growth of the mesenchymal stem cells market.
Coastal Signings
Zip Zone Supermart
Nhandinhkeo
23winn Art
Kannan Aminal Welfare
Loan 112
Rent A Car Makkah
Aditya Kashyap
Saneesh
Mc876